“…1,2 An increasing prevalence of the subclinical and silent forms of CD, characterized by few or even absence of symptoms was reported, 3,4 thus the identification of risk groups could represent a key factor for an early diagnosis of CD with consequent decreased risk of developing malignant and nonmalignant complications. [1][2][3] In addition, patients with CD often show an impairment of nutritional status, either those with the classic or the subclinical form of the disease [4][5][6] and strict adherence to GFD was found to improve but not to completely normalize the body composition in these patients. 5,6 A great prevalence of CD was recently reported among patients with low high-density lipoprotein-cholesterol (HDL-C) concentration, 7 probably as a consequence of decreased lipid absorption, reduction in cholesteroltransporting lipoproteins, and decreased apolipoprotein (Apo)-AI secretion from the altered small bowel mucosa.…”